Braskem and Haldor Topsoe have reached mechanical completion of the MOSAIK™ process step of their demonstration plant that will produce bio-based MEG (Monoethylene glycol) from sugars. The demonstration plant, located in Lyngby, Denmark, is an important step to upscale the MOSAIK™ solution and begin production at an industrial scale, which is planned to commence in 2023. The plant demonstrates all key design features of the technology and can produce more than 100 tons per year of glycolaldehyde, which is converted into MEG in the next process step.
Construction and pre-commissioning of the MOSAIK™ process step have been completed as planned and on schedule. The next activities in this part of the demonstration plant will be start-up and operation with the aim to achieve key technical targets and confirm economic feasibility of the process. Operation will begin March 1.
In parallel with operating the first process step, the partners will complete the construction of the next process step, the downstream conversion to MEG. Mechanical completion is expected before the end of 2019.
“Haldor Topsoe is a world leader within catalytic solutions, and we are determined to maintain that position also in the renewables arena. So we are extremely pleased to be able to begin the next phase of the validation of the MOSAIK™ solution for bio-based MEG together with Braskem. Our goal is to show that innovative catalytic technologies can make chemicals from biomass a commercially attractive option,” said Kim Knudsen, Executive Vice President at Haldor Topsoe.
Topsoe delivers a packaged solution for this project with Braskem, including process design, engineering, catalyst, and technology.
The demonstration plant will use sugar as feedstock and produce more than 100 tons per year of glycolaldehyde, which is the precursor for MEG that is used to produce bio-based PET plastic.
IL BIOECONOMISTA 